Canna~Fangled Abstracts Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials Journal List BMC Psychiatry v.24; 2024 PMC10768432 As a library, NLM provides access to scientific…Freedom WaresJanuary 8, 2024
